Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

With overlooked reimbursement opportunities in the Payment-Driven Payment Model (PDPM) relatively common, nursing home ...

If you think physical therapy is only about rehabilitation after surgery or recovering from an accident, think again. For the ...

Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...

We recently compiled a list of the 9 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a look at where iCAD, Inc. (NASDAQ:ICAD) stands against the other AI stocks.

Studies from Munich University highlighted quality of life in bladder and prostate cancer at ASCO 2025 Genitourinary Cancers ...

Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and ...

Study uncovers connection between early ovary removal and reduced brain white matter, raising questions about long-term ...

VATICAN CITY (RNS) – On Pope Francis’ fifth day in a Rome hospital, doctors repeated their assessment that his condition was ...

Kaitlyn Bristowe opened up about her past mental health struggles and how a Care Bear gifted by her stepdad helped get her ...